Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 58

1.

Pathogenesis and host response in Syrian hamsters following intranasal infection with Andes virus.

Safronetz D, Zivcec M, Lacasse R, Feldmann F, Rosenke R, Long D, Haddock E, Brining D, Gardner D, Feldmann H, Ebihara H.

PLoS Pathog. 2011 Dec;7(12):e1002426. doi: 10.1371/journal.ppat.1002426. Epub 2011 Dec 15.

2.

Mutagenesis of surfactant protein D informed by evolution and x-ray crystallography enhances defenses against influenza A virus in vivo.

Crouch E, Nikolaidis N, McCormack FX, McDonald B, Allen K, Rynkiewicz MJ, Cafarella TM, White M, Lewnard K, Leymarie N, Zaia J, Seaton BA, Hartshorn KL.

J Biol Chem. 2011 Nov 25;286(47):40681-92. doi: 10.1074/jbc.M111.300673. Epub 2011 Sep 30.

3.

Assessment of the antiviral properties of recombinant porcine SP-D against various influenza A viruses in vitro.

Hillaire ML, van Eijk M, van Trierum SE, van Riel D, Saelens X, Romijn RA, Hemrika W, Fouchier RA, Kuiken T, Osterhaus AD, Haagsman HP, Rimmelzwaan GF.

PLoS One. 2011;6(9):e25005. doi: 10.1371/journal.pone.0025005. Epub 2011 Sep 14.

4.

Histopathological and immunohistochemical findings of 20 autopsy cases with 2009 H1N1 virus infection.

Nakajima N, Sato Y, Katano H, Hasegawa H, Kumasaka T, Hata S, Tanaka S, Amano T, Kasai T, Chong JM, Iizuka T, Nakazato I, Hino Y, Hamamatsu A, Horiguchi H, Tanaka T, Hasegawa A, Kanaya Y, Oku R, Oya T, Sata T.

Mod Pathol. 2012 Jan;25(1):1-13. doi: 10.1038/modpathol.2011.125. Epub 2011 Aug 26. Erratum in: Mod Pathol. 2012 Mar;25(3):492. Iiduka, Toshihiko [corrected to Iizuka, Toshihiko]; Hasagawa, Akio [corrected to Hasegawa, Akio].

5.

Serial histopathological examination of the lungs of mice infected with influenza A virus PR8 strain.

Fukushi M, Ito T, Oka T, Kitazawa T, Miyoshi-Akiyama T, Kirikae T, Yamashita M, Kudo K.

PLoS One. 2011;6(6):e21207. doi: 10.1371/journal.pone.0021207. Epub 2011 Jun 20.

6.

A case of successful treatment with polymyxin B-immobilized fiber column direct hemoperfusion in acute respiratory distress syndrome after influenza A infection.

Yatera K, Yamasaki K, Kawanami T, Tokuyama S, Ogoshi T, Kouzaki M, Nagata S, Nishida C, Yoshii C, Mukae H.

Intern Med. 2011;50(6):601-5. Epub 2011 Mar 15.

7.

Extracorporeal membrane oxygenation for severe refractory respiratory failure secondary to 2009 H1N1 influenza A.

Turner DA, Rehder KJ, Peterson-Carmichael SL, Ozment CP, Al-Hegelan MS, Williford WL, Peters MA, Noble PW, Cheifetz IM.

Respir Care. 2011 Jul;56(7):941-6. doi: 10.4187/respcare.01066. Epub 2011 Feb 21.

8.

Laninamivir and its prodrug, CS-8958: long-acting neuraminidase inhibitors for the treatment of influenza.

Yamashita M.

Antivir Chem Chemother. 2010;21(2):71-84. doi: 10.3851/IMP1688. Review.

PMID:
21107016
9.

Development of an enzyme-linked immunosorbent assay for measurement of rat pulmonary surfactant protein D using monoclonal antibodies.

Murata M, Otsuka M, Mizuno H, Shiratori M, Miyazaki S, Nagae H, Kanazawa S, Hamaoki M, Kuroki Y, Takahashi H.

Exp Lung Res. 2010 Oct;36(8):463-8. doi: 10.3109/01902141003746371.

PMID:
20939757
10.

Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.

Watanabe A, Chang SC, Kim MJ, Chu DW, Ohashi Y; MARVEL Study Group..

Clin Infect Dis. 2010 Nov 15;51(10):1167-75. doi: 10.1086/656802. Epub 2010 Oct 11.

PMID:
20936975
11.

Methylprednisolone infusion for life-threatening H1N1-virus infection.

Confalonieri M, Cifaldi R, Dreas L, Viviani M, Biolo M, Gabrielli M.

Ther Adv Respir Dis. 2010 Aug;4(4):233-7. doi: 10.1177/1753465810376951. Epub 2010 Jul 16.

PMID:
20639272
12.

A case of severe ARDS caused by novel swine-origin influenza (A/H1N1pdm) virus: a successful treatment with direct hemoperfusion with polymyxin B-immobilized fiber.

Yokoyama T, Tateishi K, Tsushima K, Agatsuma T, Yamamoto H, Koizumi T, Kubo K.

J Clin Apher. 2010;25(6):350-3. doi: 10.1002/jca.20252.

PMID:
20623785
13.

2009 pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States.

Shieh WJ, Blau DM, Denison AM, Deleon-Carnes M, Adem P, Bhatnagar J, Sumner J, Liu L, Patel M, Batten B, Greer P, Jones T, Smith C, Bartlett J, Montague J, White E, Rollin D, Gao R, Seales C, Jost H, Metcalfe M, Goldsmith CS, Humphrey C, Schmitz A, Drew C, Paddock C, Uyeki TM, Zaki SR.

Am J Pathol. 2010 Jul;177(1):166-75. doi: 10.2353/ajpath.2010.100115. Epub 2010 May 27.

14.

Update on acute lung injury and critical care medicine 2009.

Matthay MA, Idell S.

Am J Respir Crit Care Med. 2010 May 15;181(10):1027-32. doi: 10.1164/rccm.201001-0074UP. Review. No abstract available.

15.

Recent advances in alveolar biology: evolution and function of alveolar proteins.

Orgeig S, Hiemstra PS, Veldhuizen EJ, Casals C, Clark HW, Haczku A, Knudsen L, Possmayer F.

Respir Physiol Neurobiol. 2010 Aug 31;173 Suppl:S43-54. doi: 10.1016/j.resp.2010.04.023. Epub 2010 Apr 28. Review.

16.

Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection.

Sugaya N, Ohashi Y.

Antimicrob Agents Chemother. 2010 Jun;54(6):2575-82. doi: 10.1128/AAC.01755-09. Epub 2010 Apr 5.

17.

Hydrocortisone therapy for patients with H1N1 influenza A infection.

Namendys-Silva SA, Hernández-Garay M.

Intensive Care Med. 2010 Jun;36(6):1097; author reply 1100-1. doi: 10.1007/s00134-010-1814-8. Epub 2010 Mar 30. No abstract available.

PMID:
20352193
18.

Surfactant replacement therapy in influenza A H1N1.

Skokić F, Hudić I, Hotić N, Cŏlić B, Praso M, Bacaj D.

Pediatr Infect Dis J. 2010 Apr;29(4):387. doi: 10.1097/INF.0b013e3181cf2eaa. No abstract available.

PMID:
20351534
19.

Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses.

Kiso M, Kubo S, Ozawa M, Le QM, Nidom CA, Yamashita M, Kawaoka Y.

PLoS Pathog. 2010 Feb 26;6(2):e1000786. doi: 10.1371/journal.ppat.1000786.

20.

Pharmacokinetics and disposition of CS-8958, a long-acting prodrug of the novel neuraminidase inhibitor laninamivir in rats.

Koyama K, Takahashi M, Nakai N, Takakusa H, Murai T, Hoshi M, Yamamura N, Kobayashi N, Okazaki O.

Xenobiotica. 2010 Mar;40(3):207-16. doi: 10.3109/00498250903447691.

PMID:
20146556

Supplemental Content

Support Center